Episode 42: Vedicinals9 - Joachim Gerlach
Listen now
Description
With the established medical system offering few options to treat Long Covid holistically - most sufferers are at best only being offered symptom management - many are turning to alternative therapies.  This week we spoke to Joachim Gerlach, chairman of Vedicinals, who have developed the nutraceutical Vedicinals9 for the treatment of acute and Long Covid.  This nutraceutical, consisting of nine bio-active molecules targeting specific pathways, draws on traditional ayurvedic medicine alongside modern science to offer a supplement which, from pre-clinical and clinical trials, seems to be having a positive effect.
More Episodes
Dr Theoharis Theoharides, aka “The Mast Cell Master”, has been exploring the world of Mast Cells, their influence on our bodily functions, neurology and genetic make up, for over half a century. The Director of the Center of Excellence for Neuroinflammation Research and Professor at the...
Published 06/11/24
Conor Browne, an independent Biorisk Consultant, analyses biosecurity risks for governmental bodies, commercial enterprises and NGOs, aiding with business continuity, forecasting and policy. He understood that Covid-19 was airborne in February 2020 but, he says, “it’s the first message that...
Published 05/23/24